Earnings Call · Q2 FY2023·2023-08-12

Q2 23EPS -22.22%·Rev n/aQ1 23EPS +28.57%·Rev n/aQ4 22EPS -21.43%·Rev n/aQ3 22EPS -21.43%·Rev n/a⚠ consensus missing

Apyx Medical Corp APYX

Charles Goodwin — Chief Executive Officer

Tara Semb — Chief Financial Officer

+20.1%1d on move date+20.2% vs SPY3d+13.0%5d+7.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more APYX calls or request research access.

More APYX calls Browse calls Request research access